Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

LSD1 inhibitors for anticancer therapy: a patent review (2017-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 9, 2022 Category: Drugs & Pharmacology Authors: Yi-Xin Lv Sheng Tian Zhou-Dong Zhang Tao Feng Huan-Qiu Li Source Type: research

Iron oxide nanoparticles for biomedical applications: an updated patent review (2015 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - August 9, 2022 Category: Drugs & Pharmacology Authors: Zeyuan Mao Xin Li Pengfei Wang Hailong Yan Source Type: research

Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - July 5, 2022 Category: Drugs & Pharmacology Authors: Benjamin Zagiel Patricia Melnyk Philippe Cotelle Source Type: research

Butyrylcholinesterase inhibitors as potential anti-Alzheimer ’s agents: an updated patent review (2018-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 23, 2022 Category: Drugs & Pharmacology Authors: Jos é G. Fernández-Bolaños Óscar López Source Type: research

An updated patent review on monoamine oxidase (MAO) inhibitors
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 9, 2022 Category: Drugs & Pharmacology Authors: Paolo Guglielmi Simone Carradori Ilaria D ’Agostino Cristina Campestre Jacobus P. Petzer Source Type: research

Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - June 2, 2022 Category: Drugs & Pharmacology Authors: Sridhar Goud Nerella Priti Singh Mohammed Arifuddin Claudiu T Supuran Source Type: research

A patent review of anticancer CDK2 inhibitors (2017 –present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 26, 2022 Category: Drugs & Pharmacology Authors: Mohamed A. Said Mohamed A. Abdelrahman Mohammed A.S. Abourehab Mohamed Fares Wagdy M. Eldehna Source Type: research

P2X receptor antagonists and their potential as therapeutics: a patent review (2010 –2021)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - May 11, 2022 Category: Drugs & Pharmacology Authors: Chianna Dane Leanne Stokes William T Jorgensen Source Type: research

Carbon-11 patents (2012 –2022): synthetic methodologies and novel radiotracers for PET imaging
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 28, 2022 Category: Drugs & Pharmacology Authors: Sridhar Goud Nerella Priti Singh Sanam Tulja Source Type: research

Anti-viral activity of thiazole derivatives: an updated patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 27, 2022 Category: Drugs & Pharmacology Authors: Thoraya A. Farghaly Amani M. R. Alsaedi Noof A. Alenazi Marwa F. Harras Source Type: research

ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 25, 2022 Category: Drugs & Pharmacology Authors: Carlotta Granchi Source Type: research

Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 12, 2022 Category: Drugs & Pharmacology Authors: Sehrish Bano Mariya Al-Rashida Rima D Alharthy Imtiaz Ali Khan Jamshed Iqbal Source Type: research

Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 12, 2022 Category: Drugs & Pharmacology Authors: Malliga R. Iyer Biswajit Kundu Casey M. Wood Source Type: research

A patent review of adenosine A2B receptor antagonists (2016-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 7, 2022 Category: Drugs & Pharmacology Authors: Beatrice Francucci Diego Dal Ben Catia Lambertucci Andrea Spinaci Rosaria Volpini Gabriella Marucci Michela Buccioni Source Type: research

The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - April 4, 2022 Category: Drugs & Pharmacology Authors: Sofia Ferrer ​ Michael E. Muratore Peter Buijnsters Source Type: research